Press release
Neuromyelitis Optica Therapeutics Treatment Market Size Report 2034: Major Companies, Emerging Drugs, Clinical Trials, MOA, FDA Approvals | DelveInsight
Neuromyelitis Optica Drugs Market
Discover which therapies are expected to grab the Neuromyelitis Optica Market Share @ Neuromyelitis Optica Market Outlook- https://www.delveinsight.com/sample-request/neuromyelitis-optica-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Neuromyelitis Optica Market Report
• According to the findings, neuromyelitis optica characteristically occurs in females and younger patients between 30 and 40 years of age. Pediatric cases of neuromyelitis optica are rare but have been reported occasionally.
• According to the findings, over 95% of neuromyelitis optica patients report no family history of the disease. Additionally, there is a strong association with a personal or family history of autoimmunity, which is present in 50% of cases.
• The leading Neuromyelitis Optica Companies such as Bio-Thera Solutions, Reistone Biopharma Limited, TG Therapeutics and others.
• Promising Neuromyelitis Optica Pipeline Therapies such as BAT4406F, SHR1459, Ublituzimab and others.
Stay ahead in the Neuromyelitis Optica Therapeutics Market with DelveInsight's Strategic Report @ Neuromyelitis Optica Market Outlook- https://www.delveinsight.com/sample-request/neuromyelitis-optica-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Neuromyelitis Optica Epidemiology Segmentation in the 7MM
• Total Neuromyelitis Optica Prevalent Cases
• Neuromyelitis Optica Diagnosed and treatable Cases
• Neuromyelitis Optica Gender-Specific Cases
Download the report to understand which factors are driving Neuromyelitis Optica Epidemiology trends @ Neuromyelitis Optica Prevalence- https://www.delveinsight.com/sample-request/neuromyelitis-optica-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Neuromyelitis Optica Marketed Drugs
• SOLIRIS (eculizumab): Alexion Pharmaceutical
In June 2019, the FDA approved SOLIRIS for the treatment of neuromyelitis optica spectrum disorder in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. It is the first drug specifically approved by the FDA specifically for neuromyelitis optica spectrum disorder. Eculizumab is an mAb that targets the C5 antibody. FDA granted Priority Review for the application of Soliris by Alexion Pharmaceuticals, expediting the approval of the drug.
• UPLIZNA (inebilizumab-cdon): Mitsubishi Chemical Group Corporation
The neuromyelitis optica spectrum disorder patients were offered an additional treatment option when the FDA approved a second drug, UPLIZNA injection for intravenous use, in adult patients with a particular antibody (patients who are anti-aquaporin-4 or AQP4 antibody positive). This drug was approved based on a clinical study of 230 adult patients that evaluated the efficacy and safety of intravenous Uplizna. During the 197-day study, the risk of an NMOSD relapse in the 161 anti-AQP4 antibody-positive patients who were treated with UPLIZNA was reduced by 77% when compared to the placebo treatment group.
Leber Hereditary Optic Neuropathy Drugs and Companies
• Bio-Thera Solutions: BAT4406F
• Reistone Biopharma Limited: SHR1459
• TG Therapeutics: Ublituzimab
To learn more about Neuromyelitis Optica treatment guidelines, visit @ Chr Neuromyelitis Optica Treatment Market Landscape- https://www.delveinsight.com/sample-request/neuromyelitis-optica-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Neuromyelitis Optica Treatment Market Landscape
The Neuromyelitis Optica treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Neuromyelitis Optica has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
Scope of the Neuromyelitis Optica Market Report
• Coverage- 7MM
• Study Period- 2020-2034
• Neuromyelitis Optica Companies- Bio-Thera Solutions, Reistone Biopharma Limited, TG Therapeutics and others.
• Neuromyelitis Optica Pipeline Therapies- BAT4406F, SHR1459, Ublituzimab and others.
• Neuromyelitis Optica Market Dynamics: Neuromyelitis Optica Market Drivers and Barriers
• Neuromyelitis Optica Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Neuromyelitis Optica Drugs in development @ Neuromyelitis Optica Clinical Trials Assessment- https://www.delveinsight.com/sample-request/neuromyelitis-optica-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Report Introduction
3. Neuromyelitis optica (NMO) Market Overview at a Glance
4. Executive Summary of Neuromyelitis optica (NMO)
5. Disease Background and Overview
6. Epidemiology and Patient Population
7. Marketed Drugs
8. Patient Journey
9. Market Outlook
10. Neuromyelitis optica (NMO) 7 Major Market Analysis
11. United States Market Size
12. EU-4 and the UK Market
13. Japan Market Size
14. SWOT Analysis
15. KOL Views
16. Appendix
17. DelveInsight Capabilities
18. Disclaimer
19. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuromyelitis Optica Therapeutics Treatment Market Size Report 2034: Major Companies, Emerging Drugs, Clinical Trials, MOA, FDA Approvals | DelveInsight here
News-ID: 4128849 • Views: …
More Releases from DelveInsight Business Research LLP
Mobile Clinics Market Forecast Report 2032: Size, Share, and Strategic Insights …
DelveInsight's Mobile Clinics Market Insights Report 2032 provides the current and forecast market analysis, individual leading Mobile Clinics Companies market shares, challenges, Mobile Clinics Market Drivers, barriers, trends, and key market Mobile Clinics companies in the market.
To read more about the latest highlights related to the Mobile Clinics Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/Mobile-Clinics-Market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Mobile Clinics Market…
Vein Illumination Devices Market Outlook Report 2032: Current Scenario, Growth O …
DelveInsight's Vein Illumination Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Vein Illumination Devices Companies market shares, challenges, Vein Illumination Devices Market Drivers, barriers, trends, and key market Vein Illumination Devices companies in the market.
To read more about the latest highlights related to the Vein Illumination Devices Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key…
Bioanalytical Testing Services Market Forecast Report 2032: Size, Share, and Str …
DelveInsight's Bioanalytical Testing Services Market Insights Report 2032 provides the current and forecast market analysis, individual leading Bioanalytical Testing Services Companies market shares, challenges, Bioanalytical Testing Services Market Drivers, barriers, trends, and key market Bioanalytical Testing Services companies in the market.
To read more about the latest highlights related to the Bioanalytical Testing Services Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/bioanalytical-testing-services-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key…
Thyroid Gland Disorder Treatment Market Forecast Report 2032 by DelveInsight: Si …
DelveInsight's Thyroid Gland Disorder Treatment Market Insights Report 2032 provides the current and forecast market analysis, individual leading Thyroid Gland Disorder Treatment Companies market shares, challenges, Thyroid Gland Disorder Treatment Market Drivers, barriers, trends, and key market Thyroid Gland Disorder Treatment companies in the market.
To read more about the latest highlights related to the Thyroid Gland Disorder Treatment Market, get a snapshot of the key highlights entailed in the Market…
More Releases for Neuromyelitis
Neuromyelitis Optica Market Detailed Industry Report Analysis 2025-2034
Introduction
Neuromyelitis optica (NMO), also known as Devic's disease, is a rare autoimmune disorder of the central nervous system characterized by severe inflammation of the optic nerves and spinal cord. Patients often experience vision loss, paralysis, sensory impairment, and bladder dysfunction. Once considered a variant of multiple sclerosis (MS), NMO is now recognized as a distinct condition, thanks to advancements in diagnostics such as aquaporin-4 (AQP4) antibody testing.
Though rare, NMO can…
Neuromyelitis Optica Spectrum Disorder Market
According to a new market research report published by Global Market Estimates, the Global Neuromyelitis Optica Spectrum Disorder Market is projected to grow at a CAGR of 6.2% from 2023 to 2028.
F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi (France), Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Zydus Cadila, Boehringer Ingelheim International GmbH., Apotex Inc., and AstraZeneca among others, are some of the key players in the global…
Neuromyelitis Optica Drug Market Therapeutic Survey Reviews, Analysis 2025
The report titled “Neuromyelitis Optica Drug Market” has recently added by MarketInsightsReports to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners, and industry experts.
The Neuromyelitis Optica Drug was valued…
Top News: Neuromyelitis Optica Spectrum Disorder Market Advancements 2019 - 2027
Neuromyelitis Optica Spectrum Disorder Market: Introduction
Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disorder of central nervous system which was previously known as Devic disease or neuromyelitis optica (NMO). It is a rare debilitating and lifelong disease characterized by inflammation in spinal cord and optic nerve.
View Report : https://www.transparencymarketresearch.com/neuromyelitis-optica-spectrum-disorder-market.html
People with neuromyelitis optica spectrum disorder experience symptoms such as paralysis, muscle weakness, and blindness. Neuromyelitis optica spectrum disorder is most common…
Neuromyelitis Optica Therapy Market 2020 Analysis and Research Report 2025
The Neuromyelitis Optica Therapy Market report is a collection of useful information, quantitative and qualitative estimation by industry experts, the contribution from industry connoisseurs and industry accomplices across the value chain. Furthermore, the report also provides the qualitative results of diverse market factors on its geographies and segments.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and…
Global Neuromyelitis Optica Drug Market Research Report 2016
Qyresearchreports include new market research report”Global Neuromyelitis Optica Drug Market Research Report 2016″ to its huge collection of research reports.
A new research report on the global Neuromyelitis Optica Drug market offers a 360-degree overview of it. The report discusses the market in significant details and elucidates all aspects of the global Neuromyelitis Optica Drug market likely to impact its growth trajectory in the upcoming years. Major market stimulants and deterrents…
